Edition:
United Kingdom

Teligent Inc (TLGT.OQ)

TLGT.OQ on NASDAQ Stock Exchange Global Select Market

3.97USD
19 Jul 2018
Change (% chg)

$-0.09 (-2.22%)
Prev Close
$4.06
Open
$4.03
Day's High
$4.03
Day's Low
$3.93
Volume
7,564
Avg. Vol
156,435
52-wk High
$8.80
52-wk Low
$2.43

Chart for

About

Teligent, Inc. is a specialty generic pharmaceutical company. Under the Company's own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 16 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December... (more)

Overall

Beta: 1.56
Market Cap(Mil.): $379.08
Shares Outstanding(Mil.): 53.39
Dividend: --
Yield (%): --

Financials

  TLGT.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -0.15 -- --
ROI: -4.71 15.07 14.61
ROE: -13.46 16.60 16.34

BRIEF-Teligent, Inc. Announces Qtrly Loss Per Share $0.11​

* TELIGENT, INC. ANNOUNCES FOURTH QUARTER AND YEAR END 2017 RESULTS

15 Mar 2018

BRIEF-Teligent Inc Announces FDA Approval Of Betamethasone Dipropionate Lotion USP 0.05 Pct

* TELIGENT INC ANNOUNCES FDA APPROVAL OF BETAMETHASONE DIPROPIONATE LOTION USP (AUGMENTED), 0.05%

14 Feb 2018

BRIEF-Teligent Appoints Damian Finio As Chief Financial Officer

* TELIGENT, INC. ANNOUNCES THE APPOINTMENT OF DAMIAN FINIO AS CHIEF FINANCIAL OFFICER

26 Jan 2018

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF81.08 +0.42
Taro Pharmaceutical Industries Ltd. (TARO.N) $113.81 -0.55

Earnings vs. Estimates